https://www.selleckchem.com/products/blz945.html
RESULTS CXA and active function were moderately correlated in the upper limb (P less then 0.0001-0.0004, r = 0.476-0.636) and weakly correlated in the lower limb (P less then 0.0001-0.0284, r = 0.186-0.285) at Weeks 4 and 12 of each open-label cycle. Changes in CXA and active function were weakly correlated only in the upper limb (Cycle 2 Week 12, P = 0.0160, r = 0.213; Cycle 3 Week 4, P = 0.0031, r = 0.296). Across cycles, CXA improvements peaked at Week 4, while functional improvements peaked at Week 12. CONCLUSION CXA is a valid m
Like
Comment
Share
